Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

196 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
No increased risk of Kaposi sarcoma relapse in patients with controlled HIV-1 infection after switching protease inhibitor-based antiretroviral therapy.
Lajaunie R, Cuzin L, Palich R, Makinson A, Bani-Sadr F, Duvivier C, Arvieux C, Rey D, Poizot-Martin I, Delpierre C, Delobel P, Martin-Blondel G; And The Dat’AIDS study group. Lajaunie R, et al. Among authors: cuzin l. HIV Med. 2022 Mar;23(3):301-306. doi: 10.1111/hiv.13168. Epub 2021 Oct 19. HIV Med. 2022. PMID: 34668293 Free article.
Factors associated with mortality in human immunodeficiency virus type 1-infected adults initiating protease inhibitor-containing therapy: role of education level and of early transaminase level elevation (APROCO-ANRS EP11 study). The Antiprotéases Cohorte Agence Nationale de Recherches sur le SIDA EP 11 study.
Lewden C, Raffi F, Cuzin L, Cailleton V, Vildé JL, Chêne G, Allavena C, Salamon R, Leport C. Lewden C, et al. Among authors: cuzin l. J Infect Dis. 2002 Sep 1;186(5):710-4. doi: 10.1086/342047. Epub 2002 Jul 29. J Infect Dis. 2002. PMID: 12195361 Clinical Trial.
Enfuvirtide for prophylaxis against HIV infection.
Cuzin L, Alvarez M. Cuzin L, et al. N Engl J Med. 2003 Nov 27;349(22):2169-70; author reply 2169-70. doi: 10.1056/NEJM200311273492218. N Engl J Med. 2003. PMID: 14645649 No abstract available.
Incidence of and risk factors for adverse drug reactions in a prospective cohort of HIV-infected adults initiating protease inhibitor-containing therapy.
Duval X, Journot V, Leport C, Chêne G, Dupon M, Cuzin L, May T, Morlat P, Waldner A, Salamon R, Raffi F; Antiprotease Cohort (APROCO) Study Group. Duval X, et al. Among authors: cuzin l. Clin Infect Dis. 2004 Jul 15;39(2):248-55. doi: 10.1086/422141. Epub 2004 Jul 1. Clin Infect Dis. 2004. PMID: 15307035
Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
Delobel P, Nugeyre MT, Cazabat M, Sandres-Sauné K, Pasquier C, Cuzin L, Marchou B, Massip P, Cheynier R, Barré-Sinoussi F, Izopet J, Israël N. Delobel P, et al. Among authors: cuzin l. J Virol. 2006 Oct;80(20):10229-36. doi: 10.1128/JVI.00965-06. J Virol. 2006. PMID: 17005700 Free PMC article.
Correlates of late HIV diagnosis: implications for testing policy.
Delpierre C, Dray-Spira R, Cuzin L, Marchou B, Massip P, Lang T, Lert F; VESPA Study Group. Delpierre C, et al. Among authors: cuzin l. Int J STD AIDS. 2007 May;18(5):312-7. doi: 10.1258/095646207780749709. Int J STD AIDS. 2007. PMID: 17524190 Free PMC article.
Routine testing to reduce late HIV diagnosis in France.
Delpierre C, Cuzin L, Lert F. Delpierre C, et al. Among authors: cuzin l. BMJ. 2007 Jun 30;334(7608):1354-6. doi: 10.1136/bmj.39225.458218.94. BMJ. 2007. PMID: 17600025 Free PMC article. Review.
196 results